Related Experiment Video
Updated: Jan 25, 2026
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease
1a Eugene McDermott Center for Human Growth and Development, Department of Molecular Genetics , University of Texas Southwestern Medical Center , Dallas , TX , USA.
Insights
Fatty liver disease (FLD) is common and linked to a gene variant (rs738409) in PNPLA3. Understanding this gene
Area of Science:
- Hepatology and genetics
- Molecular biology
- Metabolic disorders
Background:
- Fatty liver disease (FLD) impacts over a third of Western populations and is rising in US children.
- It is a primary driver of obesity and liver transplantations.
- Current therapeutic interventions for FLD are ineffective, necessitating deeper mechanistic understanding.
Purpose of the Study:
- To review advancements in understanding the role of patatin-like phospholipase domain-containing protein 3 (PNPLA3) in FLD pathogenesis.
- To explore potential therapeutic strategies targeting PNPLA3 to mitigate FLD progression.
Main Methods:
- Literature review focusing on PNPLA3 genetics, protein function, and lipid metabolism.
- Analysis of studies investigating the rs738409 variant and its impact on liver health.
- Exploration of current and emerging therapeutic approaches for FLD.
Main Results:
- The PNPLA3 rs738409 variant (I148M) is strongly associated with FLD progression.
- PNPLA3 plays a critical role in regulating lipid droplet dynamics within hepatocytes.
- Mechanisms linking PNPLA3 dysfunction to steatosis are increasingly elucidated.
Conclusions:
- Further research into PNPLA3's precise role in lipid metabolism is crucial for developing effective FLD treatments.
- Targeting PNPLA3 offers a promising avenue for ameliorating this widespread liver condition.
- Understanding the genetic underpinnings of FLD is key to addressing its growing public health impact.
Abstract:
Fatty liver disease (FLD) affects more than one-third of the population in the western world and an increasing number of children in the United States. It is a leading cause of obesity and liver transplantation. Mechanistic insights into the causes of FLD are urgently needed since no therapeutic intervention has proven to be effective. A sequence variation in patatin like phospholipase domain-containing protein 3 (PNPLA3), rs 738409, is strongly associated with the progression of fatty liver disease. The resulting mutant causes a substitution of isoleucine to methionine at position 148. The underlying mechanism of this disease remains unsolved although several studies have illuminated key insights into its pathogenesis. This review highlights the progress in our understanding of PNPLA3 function in lipid droplet dynamics and explores possible therapeutic interventions to ameliorate this human health hazard.
More Related Videos
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
02:37Oxidation of Alcohols
The process of oxidation in a chemical reaction is observed in any of the three forms:
02:29Ethers from Alcohols: Alcohol Dehydration and Williamson Ether Synthesis
Ethers can be prepared from organic compounds by various methods. Some of them are discussed below,
Preparation of Ethers by Alcohol Dehydration
In this method, in the presence of protic acids, alcohol dehydrates to produce alkenes and ethers under different conditions. For example, in the presence of sulphuric acid, dehydration of ethanol at 413 K yields ethoxyethane, whereas it yields ethene at 443 K.
02:31Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
01:28Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...